Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | SPHK2 | Q9NRA0 | 5/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 5/20 | 0.38 |
| ▸ | MET | P08581 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7075442 | 0.77 | TSHR (0.45) | FFAR4L3MBTL1DAORAB9ATSHR | |
| SCHEMBL7084329 | 0.76 | L3MBTL1 (0.43) | FFAR4L3MBTL1DAOMETRAB9A | |
| SCHEMBL7097280 | 0.76 | MAPT (0.45) | FFAR4L3MBTL1DAORAB9ANPC1 | |
| SCHEMBL7072311 | 0.75 | L3MBTL1 (0.43) | L3MBTL1DAORAB9ATSHRLMNA | |
| SCHEMBL7116372 | 0.74 | L3MBTL1 (0.59) | FFAR4L3MBTL1DAOMETRAB9A | |
| SCHEMBL7097252 | 0.72 | MAPT (0.45) | FFAR4L3MBTL1RAB9ANPC1MAPK1 | |
| SCHEMBL7084333 | 0.72 | L3MBTL1 (0.42) | FFAR4L3MBTL1DAORAB9ATSHR | |
| SCHEMBL12747582 | 0.72 | L3MBTL1 (0.62) | FFAR4L3MBTL1DAOMETRAB9A | |
| SCHEMBL7087242 | 0.72 | L3MBTL1 (0.40) | FFAR4L3MBTL1DAOMETRAB9A | |
| SCHEMBL27536208 | 0.71 | L3MBTL1 (0.66) | FFAR4L3MBTL1DAOSPHK2SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030199698-A1 | Carbamic acid esters as inhibitors of factor xa | MERCK PATENT GMBH (DE) | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199698-A1 | Carbamic acid esters as inhibitors of factor xa | F11, F12, F13A1 | FFAR4 1040/4885L3MBTL1 1569/4885DAO 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.